← Leaderboards
Richard G Pestell
Yeshiva University
$31,985,036
Attributed
$33,183,897
Total exposure
61
Grants
59
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$73,448,195 · 63
By mechanism
P30$53,222,303 · 52
R01$18,779,811 · 7
R43$648,896 · 1
R21$382,756 · 1
S10$273,969 · 1
R29$140,460 · 1
Top collaborators
- Erik Knudsen5 shared
- Anthony W Ashton2 shared
- Xuanmao Jiao2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer CenterTranslational ResearchResearch PersonnelProgramsFundingResource SharingMemberBaseClinical ResearchPeer ReviewPublicationsClinical TrialsMolecularAreaUniversitiesFacultyTumorAnticancer ResearchBasic ScienceIn VivoSignal TransductionResourcesMonitor
Grant awards (200)
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity$323,902
R43 · FY2023 · HL
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity$324,994
R43 · FY2022 · HL
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents$382,756
R21 · FY2020 · CA · contact PI
DACH1/Eya Cell fate determination factor and mammary tumorigenesis$428,056
R01 · FY2018 · CA · contact PI
DACH1/Eya Cell fate determination factor and mammary tumorigenesis$428,056
R01 · FY2017 · CA · contact PI
DACH1/Eya Cell fate determination factor and mammary tumorigenesis$331,084
R01 · FY2016 · CA · contact PI
DACH1/Eya Cell fate determination factor and mammary tumorigenesis$348,750
R01 · FY2015 · CA · contact PI
DACH1/Eya Cell fate determination factor and mammary tumorigenesis$348,750
R01 · FY2014 · CA · contact PI
Impact of Cyclin D1 Isoforms in Breast Cancer$340,445
R01 · FY2014 · CA · contact PI
Senior Leadership$288,149
P30 · FY2014 · CA · contact PI
Radiation Res & Translational Biology$276,018
P30 · FY2014 · CA · contact PI
Facilities$258,916
P30 · FY2014 · CA · contact PI
Translational Research$238,771
P30 · FY2014 · CA · contact PI
Biology of Breast Cancer$218,888
P30 · FY2014 · CA · contact PI
Data & Safety Monitoring$212,301
P30 · FY2014 · CA · contact PI
Biostatistics$201,742
P30 · FY2014 · CA · contact PI
Clinical Research Management Office$130,473
P30 · FY2014 · CA · contact PI
Bioinformatics$119,426
P30 · FY2014 · CA · contact PI
Protocol-Specific Research Support$108,971
P30 · FY2014 · CA · contact PI
Small Animal Imaging$77,486
P30 · FY2014 · CA · contact PI
X-Ray Crylatllography$76,526
P30 · FY2014 · CA · contact PI
Protocol Review and Monitoring System$73,604
P30 · FY2014 · CA · contact PI
Translational Research in Cancer$73,216
P30 · FY2014 · CA · contact PI
Developmental Funds$62,249
P30 · FY2014 · CA · contact PI
Planning and Evaluation$54,753
P30 · FY2014 · CA · contact PI
Laboratory Animal$46,026
P30 · FY2014 · CA · contact PI
Administration$45,177
P30 · FY2014 · CA · contact PI
Bioimaging$43,370
P30 · FY2014 · CA · contact PI
Flow Cytometry$40,242
P30 · FY2014 · CA · contact PI
Gastrointestinal Cancer$37,103
P30 · FY2014 · CA · contact PI
Cancer Cell Biology and Signaling$30,518
P30 · FY2014 · CA · contact PI
Molecular Biology and Genetics Program$29,960
P30 · FY2014 · CA · contact PI
Cancer Genomics$26,578
P30 · FY2014 · CA · contact PI
Biology of Prostate Cancer$26,268
P30 · FY2014 · CA · contact PI
Translational Research in Cancer$2,647,679
P30 · FY2013 · CA · contact PI
Impact of Cyclin D1 Isoforms in Breast Cancer$329,916
R01 · FY2013 · CA · contact PI
Senior Leadership$280,126
P30 · FY2013 · CA · contact PI
Radiation Res & Translational Biology$268,331
P30 · FY2013 · CA · contact PI
Facilities$251,708
P30 · FY2013 · CA · contact PI
Translational Research$232,122
P30 · FY2013 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$214,812
R01 · FY2013 · CA · contact PI
Biology of Breast Cancer$212,792
P30 · FY2013 · CA · contact PI
Data & Safety Monitoring$206,390
P30 · FY2013 · CA · contact PI
Biostatistics$196,124
P30 · FY2013 · CA · contact PI
Clinical Research Management Office$126,840
P30 · FY2013 · CA · contact PI
Bioinformatics$116,102
P30 · FY2013 · CA · contact PI
Protocol-Specific Research Support$105,939
P30 · FY2013 · CA · contact PI
Small Animal Imaging$75,327
P30 · FY2013 · CA · contact PI
X-Ray Crylatllography$74,396
P30 · FY2013 · CA · contact PI
Translational Research in Cancer$73,216
P30 · FY2013 · CA · contact PI
Translational Research in Cancer$73,216
P30 · FY2013 · CA · contact PI
Protocol Review and Monitoring System$71,555
P30 · FY2013 · CA · contact PI
Developmental Funds$60,517
P30 · FY2013 · CA · contact PI
Planning and Evaluation$53,230
P30 · FY2013 · CA · contact PI
Laboratory Animal$44,744
P30 · FY2013 · CA · contact PI
Administration$43,921
P30 · FY2013 · CA · contact PI
Bioimaging$42,162
P30 · FY2013 · CA · contact PI
Flow Cytometry$39,121
P30 · FY2013 · CA · contact PI
Gastrointestinal Cancer$36,068
P30 · FY2013 · CA · contact PI
Cancer Cell Biology and Signaling$29,667
P30 · FY2013 · CA · contact PI
Overall Quality of Programs$29,124
P30 · FY2013 · CA · contact PI
Cancer Genomics$25,838
P30 · FY2013 · CA · contact PI
Biology of Prostate Cancer$25,535
P30 · FY2013 · CA · contact PI
Translational Research in Cancer$2,947,311
P30 · FY2012 · CA · contact PI
Impact of Cyclin D1 Isoforms in Breast Cancer$350,974
R01 · FY2012 · CA
Developmental Funds$342,832
P30 · FY2012 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$310,970
R01 · FY2012 · CA · contact PI
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis$310,970
R01 · FY2012 · CA · contact PI
Senior Leadership$232,815
P30 · FY2012 · CA · contact PI
Proteomics and Molecular Characterization$186,184
P30 · FY2012 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$77,500
R01 · FY2012 · CA · contact PI
Translational Research in Cancer$74,459
P30 · FY2012 · CA · contact PI
Radiation Research and Therapeutics$30,359
P30 · FY2012 · CA · contact PI
Translational Research in Cancer$2,947,311
P30 · FY2011 · CA · contact PI
Initiation and Maintenance in Mammary Tumorigenesis$371,101
R01 · FY2011 · CA · contact PI
Developmental Funds$351,556
P30 · FY2011 · CA · contact PI
Impact of Cyclin D1 Isoforms in Breast Cancer$350,692
R01 · FY2011 · CA
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis$310,970
R01 · FY2011 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$310,970
R01 · FY2011 · CA · contact PI
Senior Leadership$238,740
P30 · FY2011 · CA · contact PI
Proteomics and Molecular Characterization$190,923
P30 · FY2011 · CA · contact PI
Translational Research in Cancer$75,000
P30 · FY2011 · CA · contact PI
Radiation Research and Therapeutics$31,130
P30 · FY2011 · CA · contact PI
Translational Research in Cancer$3,102,433
P30 · FY2010 · CA · contact PI
Initiation and Maintenance in Mammary Tumorigenesis$382,579
R01 · FY2010 · CA · contact PI
Developmental Funds$372,480
P30 · FY2010 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$320,588
R01 · FY2010 · CA · contact PI
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis$320,588
R01 · FY2010 · CA · contact PI
Regulation of cyclin D1 Expression$298,677
R01 · FY2010 · CA · contact PI
Senior Leadership$252,950
P30 · FY2010 · CA · contact PI
Impact of Cyclin D1 Isoforms in Breast Cancer$160,501
R01 · FY2010 · CA
Translational Research in Cancer$99,766
P30 · FY2010 · CA · contact PI
Translational Research in Cancer$3,102,433
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$956,943
P30 · FY2009 · CA · contact PI
Initiation and Maintenance in Mammary Tumorigenesis$382,579
R01 · FY2009 · CA · contact PI
Developmental Funds$379,725
P30 · FY2009 · CA · contact PI
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis$320,588
R01 · FY2009 · CA · contact PI
Androgen Receptor Function in Prostate Cancer$320,588
R01 · FY2009 · CA · contact PI
Regulation of cyclin D1 Expression$298,677
R01 · FY2009 · CA · contact PI
Cancer Center Administration$277,697
P30 · FY2009 · CA · contact PI
Senior Leadership$257,869
P30 · FY2009 · CA · contact PI
Cancer Genomics$249,495
P30 · FY2009 · CA · contact PI
Lab Animal$213,133
P30 · FY2009 · CA · contact PI
Proteomics and Molecular Characterization$206,221
P30 · FY2009 · CA · contact PI
Informatics$204,922
P30 · FY2009 · CA · contact PI
Biostatistics$190,228
P30 · FY2009 · CA · contact PI
Clinical Research Management Office$186,238
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$154,500
P30 · FY2009 · CA · contact PI
Transgenic Knockout Mice$153,185
P30 · FY2009 · CA · contact PI
Translational Research$152,043
P30 · FY2009 · CA · contact PI
Flow Cytometry$102,175
P30 · FY2009 · CA · contact PI
Small Animal Imaging$99,712
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$98,650
P30 · FY2009 · CA · contact PI
Protocol Specific Research Support (PSRS)$95,179
P30 · FY2009 · CA · contact PI
Data Safety Monitoring Board (DSMB)$78,331
P30 · FY2009 · CA · contact PI
X-Ray Chrystallography$74,297
P30 · FY2009 · CA · contact PI
Bioimaging$63,552
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$63,390
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$50,002
P30 · FY2009 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$45,579
P30 · FY2009 · CA · contact PI
Cell Biology and Signaling$41,351
P30 · FY2009 · CA · contact PI
Gastro Intestinal Cancer$33,625
P30 · FY2009 · CA · contact PI
Radiation Research and Therapeutics$33,625
P30 · FY2009 · CA · contact PI
Endocrine Mechanisms and Hormone Action in Cancer$33,625
P30 · FY2009 · CA · contact PI
Molecular Biology and Genetics$32,812
P30 · FY2009 · CA · contact PI
Program Planning and Evaluation$31,463
P30 · FY2009 · CA · contact PI
Immunological Mechanisms in Cancer$28,391
P30 · FY2009 · CA · contact PI
Translational Research in Cancer$3,116,058
P30 · FY2008 · CA · contact PI
Initiation and Maintenance in Mammary Tumorigenesis$382,579
R01 · FY2008 · CA · contact PI
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Cancer$301,285
R01 · FY2008 · CA · contact PI
Regulation of cyclin D1 Expression$298,677
R01 · FY2008 · CA · contact PI
Developmental Funds$234,869
P30 · FY2008 · CA · contact PI
Cancer Center Administration$171,762
P30 · FY2008 · CA · contact PI
Senior Leadership$159,498
P30 · FY2008 · CA · contact PI
Cancer Genomics$154,318
P30 · FY2008 · CA · contact PI
Lab Animal$131,828
P30 · FY2008 · CA · contact PI
Proteomics and Molecular Characterization$127,552
P30 · FY2008 · CA · contact PI
Informatics$126,749
P30 · FY2008 · CA · contact PI
Biostatistics$117,661
P30 · FY2008 · CA · contact PI
Clinical Research Management Office$115,192
P30 · FY2008 · CA · contact PI
Transgenic Knockout Mice$94,749
P30 · FY2008 · CA · contact PI
Translational Research$94,042
P30 · FY2008 · CA · contact PI
Translational Research in Cancer$63,390
P30 · FY2008 · CA · contact PI
Flow Cytometry$63,198
P30 · FY2008 · CA · contact PI
Small Animal Imaging$61,674
P30 · FY2008 · CA · contact PI
Protocol Specific Research Support (PSRS)$58,870
P30 · FY2008 · CA · contact PI
Data Safety Monitoring Board (DSMB)$48,449
P30 · FY2008 · CA · contact PI
X-Ray Chrystallography$45,954
P30 · FY2008 · CA · contact PI
Bioimaging$39,308
P30 · FY2008 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$28,192
P30 · FY2008 · CA · contact PI
Cell Biology and Signaling$25,577
P30 · FY2008 · CA · contact PI
Gastro Intestinal Cancer$20,798
P30 · FY2008 · CA · contact PI
Radiation Research and Therapeutics$20,798
P30 · FY2008 · CA · contact PI
Endocrine Mechanisms and Hormone Action in Cancer$20,798
P30 · FY2008 · CA · contact PI
Molecular Biology and Genetics$20,295
P30 · FY2008 · CA · contact PI
Program Planning and Evaluation$19,461
P30 · FY2008 · CA · contact PI
Immunological Mechanisms in Cancer$17,561
P30 · FY2008 · CA · contact PI
TRANSLATIONAL RESEARCH IN CANCER$4,309,306
P30 · FY2007 · CA · contact PI
Initiation and Maintenance in Mammary Tumorigenesis$383,611
R01 · FY2007 · CA · contact PI
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Cancer$301,285
R01 · FY2007 · CA · contact PI
Regulation of cyclin D1 Expression$298,677
R01 · FY2007 · CA · contact PI
Automated High Throughput DNA Sequencer$273,969
S10 · FY2007 · RR · contact PI
TRANSLATIONAL RESEARCH IN CANCER$57,159
P30 · FY2007 · CA · contact PI
TRANSLATIONAL RESEARCH IN CANCER$4,440,350
P30 · FY2006 · CA · contact PI
Initiation and Maintenance In Mammary Tumorigenesis$376,899
R01 · FY2006 · CA · contact PI
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Ca.$310,449
R01 · FY2006 · CA · contact PI
Regulation of cyclin D1 Expression$307,598
R01 · FY2006 · CA · contact PI
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis$257,150
R01 · FY2006 · CA · contact PI
Initiation and Maintenance In Mammary Tumorigenesis$376,273
R01 · FY2005 · CA
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis$263,338
R01 · FY2005 · CA
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Ca.$260,498
R01 · FY2005 · CA
CANCER CENTER SUPPORT GRANT$241,028
P30 · FY2005 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$204,568
R01 · FY2005 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$162,891
R01 · FY2005 · CA
CANCER CENTER SUPPORT GRANT$133,964
P30 · FY2005 · CA
REGULATION OF CYCLIN D1 EXPRESSION$77,600
R01 · FY2005 · CA
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Ca.$58,997
R01 · FY2005 · CA
CANCER CENTER SUPPORT GRANT$36,742
P30 · FY2005 · CA
CANCER CENTER SUPPORT GRANT$2,831,741
P30 · FY2004 · CA
Initiation and Maintenance In Mammary Tumorigenesis$366,980
R01 · FY2004 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$356,758
R01 · FY2004 · CA
Cyclin D1 Regulation of Nuclear Receptor Function$318,160
R01 · FY2004 · CA
REGULATION OF CYCLIN D1 EXPRESSION$314,280
R01 · FY2004 · CA
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis$263,338
R01 · FY2004 · CA
CANCER CENTER SUPPORT GRANT$2,908,354
P30 · FY2003 · CA
Initiation and Maintenance In Mammary Tumorigenesis$357,958
R01 · FY2003 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$346,366
R01 · FY2003 · CA
REGULATION OF CYCLIN D1 EXPRESSION$314,280
R01 · FY2003 · CA
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis$277,138
R01 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$2,742,137
P30 · FY2002 · CA
Initiation and Maintenance In Mammary Tumorigenesis$376,032
R01 · FY2002 · CA
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis$372,132
R01 · FY2002 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$361,938
R01 · FY2002 · CA
REGULATION OF CYCLIN D1 EXPRESSION$338,175
R01 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$2,761,760
P30 · FY2001 · CA
BREAST INDUCIBLE ANTISENSE CYCLIN D1 TRANSGENIC MICE$401,488
R01 · FY2001 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER$352,361
R01 · FY2001 · CA
REGULATION OF CYCLIN D1 EXPRESSION$339,188
R01 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$156,000
P30 · FY2001 · CA
BREAST INDUCIBLE ANTISENSE CYCLIN D1 TRANSGENIC MICE$392,295
R01 · FY2000 · CA